Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Delayed Nasdaq
Other stock markets
 18:04:57 10/05/2024 BST 		5-day change 1st Jan Change
1.22 USD +3.91% Intraday chart for NeuroSense Therapeutics Ltd. -8.29% +55.38%
05-07 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI
04-22 NeuroSense to Collaborate With Genetika+ on Alzheimer's Disease Drug Development; Shares Fall MT

Chart calendar NeuroSense Therapeutics Ltd.

603d0b497223655dff0e42293013.m0C6e3p0S3N_b3DOBo5mZpyqO_5smx4njgEOkCOEuKM.qyTvEhw8FD4VNRuYVeIlM-35A6gI71hS10Q9qXrIzNPKJOpJMzsgPw0pIQ~f8805286d4673cf67950ee9d18215a04

Upcoming events on NeuroSense Therapeutics Ltd.

28/05/2024 Q1 2024 Earnings Release (Projected)
27/08/2024 Q2 2024 Earnings Release (Projected)
26/11/2024 Q3 2024 Earnings Release (Projected)
18/03/2025 Q4 2024 Earnings Release (Projected)

Past events on NeuroSense Therapeutics Ltd.

17/04/2024 00:30 American Academy of Neurology Meeting
05/04/2024 14:29 Q4 2023 Earnings Release
19/03/2024 18:00 Roth Conference
05/12/2023 ALS MND International Symposium
05/12/2023 13:30 Amyotrophic Lateral Sclerosis Phase IIb Trial Call
28/11/2023 13:45 Q3 2023 Earnings Release
15/11/2023 ALS ONE ALS Research Symposium
10/11/2023 Neuroscience Conference
05/11/2023 BIO Europe Fall Partnering Conference
03/10/2023 Emerging Growth Conference
03/10/2023 Northeast Amyotrophic Lateral Sclerosis Meeting
14/09/2023 Treatment and Research in ALS International Pan-Asian Consortium
12/09/2023 13:30 Business Update Call
12/09/2023 05:00 H.C. Wainwright Global Investment Conference
29/08/2023 Q2 2023 Earnings Release (Projected)
24/07/2023 13:30 Business Update Call
22/07/2023 EverythingALS Digital Biomarkers Summit
11/07/2023 ENCALS Conference
21/06/2023 14:00 Maxim Group Virtual Healthcare Conference
01/06/2023 13:45 Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-5,59
-6,54
14.62%		-13,6
-13,5
-0.69%		-13,3
-13,1
-1.72%
-14,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-4,04
-6,53
38.15%		-12,3
-12,5
1.63%		-11,3
-11,5
1.51%
-13,9

Net income
Million USD		Released
Forecast
Spread 		-2,83


-4,04
-6,32
36.07%		-12,3
-12,5
1.63%		-11,3
-11,4
1.2%
-14,1

EPS
USD		Released
Forecast
Spread 		-1,54


-0,65
-0,84
22.62%		-1,07
-1,10
2.73%		-0,83
-0,82
-1.22%
-0,83

Announcement Date10/08/2114/04/2222/03/2305/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-1,26
-1,80
29.92%		-3,26
-2,04
-60.08%		-3,59
-3,30
-8.89%		-3,32
-3,65
8.94%		-3,38
-3,29
-2.83%		-3,64
-3,41
-6.68%		-3,48
-3,75
7.28%		-2,90
-3,65
20.63%		-3,29
-3,06
-7.37%
-3,19


-3,30


-3,57


-3,85

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-0,99
-1,80
44.99%		-2,72
-2,04
-33.15%		-3,48
-3,30
-5.58%		-2,99
-3,65
17.86%		-3,15
-3,29
4.14%		-3,89
-3,41
-13.95%


0,78
-3,55
122.08%		-2,95
-3,12
5.54%
-3,19


-3,30


-3,57


-3,85

Net income
Million USD		Released
Forecast
Spread 		-0,99
-1,80
44.99%		-2,72
-2,04
-33.15%		-3,48
-3,30
-5.58%		-2,99
-3,65
17.86%		-3,15
-3,29
4.14%		-3,89
-3,41
-13.95%		-5,23
-3,80
-37.5%		0,78
-3,68
121.33%		-2,95
-3,09
4.42%
-3,19


-3,30


-3,57


-3,85

EPS
USD		Released
Forecast
Spread 		-0,07
-0,16
56.25%		-0,24
-0,18
-33.33%		-0,31
-0,28
-10.71%		-0,25
-0,28
10.71%		-0,27
-0,28
3.57%		-0,33
-0,29
-13.79%		-0,44
-0,28
-57.14%		0,10
-0,26
138.46%		-0,16
-0,20
20%
-0,20


-0,21


-0,20


-0,22

Announcement Date14/04/2231/05/2231/08/2201/12/2222/03/2301/06/2316/08/2328/11/2305/04/24----

Upcoming sector events for NeuroSense Therapeutics Ltd.

12/05/2024 PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
12/05/2024 ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
12/05/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release
12/05/2024 PEPTRON, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 IMMATICS N.V.: Q1 2024 Earnings Release (Projected)
13/05/2024 SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024 PEPTIDREAM INC.: Q1 2024 Earnings Release
13/05/2024 NYKODE THERAPEUTICS: Q1 2024 Earnings Release
More events

Past sector events for NeuroSense Therapeutics Ltd.

Today TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected)
09/05/2024 21:15 ANAPTYSBIO, INC.: Q1 2024 Earnings Release
09/05/2024 21:10 ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 21:09 XENCOR, INC.: Q1 2024 Earnings Release
09/05/2024 21:02 SPYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 21:01 MACROGENICS, INC.: Q1 2024 Earnings Release
09/05/2024 21:01 ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release
09/05/2024 21:00 ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release
09/05/2024 13:00 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release
09/05/2024 12:30 WAVE LIFE SCIENCES LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. Calendar NeuroSense Therapeutics Ltd.